Besides, FKBP10 upregulation has been observed in KRAS mutation-induced lung adenocarcinoma, colorectal cancer renal cell carcinoma, gastric cancer and knockdown of FKBP10 expression could reverse the malignant phenotype, especially proliferation ability [18–21]. The gene discussed is FKBP10; the disease is gastric cancer.